Clinical Trials Directory

Trials / Completed

CompletedNCT01560481

Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers

Randomized Clinical Trial to Evaluate Safety, Tolerability and PK-PD Profile of Metformin Glycinate 620 mg,1240 mg, 2480 mg and Metformin Chlorhydrate 1000 mg of One Single Dose, Multiple Dose and After Food Intake.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Laboratorios Silanes S.A. de C.V. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Metformin Glycinate is a novel biguanide compound developed as a potential candidate for the treatment of type 2 diabetes. Metformin Glycinate was found to improve metabolic control in naive patients with type 2 diabetes. The objective of this study is to evaluate the safety, tolerability and pK profile of Metformin Glycinate 620 mg QD, 1240 mg QD, 2480 mg QD, after administration of one single dose, in step A. In step A will be included 25 volunteers. In step B the objective is to evaluate Safety, tolerability and pK profile of Metformin Glycinate 620 mg BID, after administration of multiple dose during 8 days. In step B will be included 24 volunteers.

Conditions

Interventions

TypeNameDescription
DRUGStep A: metformin glycinate 620 mg single dosemetformin glycinate 620 mg single dose
DRUGStep A: metformin glycinate 1240 mg single dosemetformin glycinate 1240 mg single dose
DRUGStep A: metformin glycinate 2480 mg single dosemetformin glycinate 2480 mg single dose
DRUGStep A: metformin hydrochloride 1000 mg single dosemetformin Chlorhydrate 1000 mg single dose
DRUGStep A: metformin glycinate 1240 mg,food intakemetformin glycinate 1240 mg, intake of food
DRUGStep B: metformin glycinate 620 mg BIDmetformin glycinate 620 mg BID, 8 days
DRUGStep B: metformin hydrochloride 500 mg BIDmetformin Chlorhydrate 500 mg BID, 8 days

Timeline

Start date
2011-12-01
Primary completion
2012-03-01
Completion
2013-03-01
First posted
2012-03-22
Last updated
2018-01-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01560481. Inclusion in this directory is not an endorsement.